E-Prescribing Software
Experience a next-generation e-prescribing platform, Surescripts-certified and EPCS-ready, engineered to simplify prescribing, accelerate authorizations, and secure every transaction.
Features That’ll Change How You Deliver Care
e-Prescription in Seconds
Transmit prescriptions instantly and securely. Auto-detect drug interactions and allergies. Use patient-specific templates for rapid, repeatable accuracy. Reduce patient costs with integrated e-Coupons.

Faster Access to Medications
Send prescriptions directly to pharmacies in real time. Save hours every week with automated prior authorizations. Enable medication reconciliation using live pharmacy data.

Medication Management Without Boundaries
Monitor prescription fulfillment status. Approve refills with a two-click workflow. Block fraud with encrypted, EHR-integrated safeguards.


Maximize Clinical Reach &
Operational Efficiency
Eliminate workflow friction with our e-Prescribing solutions. As a fully Surescripts- and EPCS-certified solution, it integrates directly with your existing EHR and clinical systems, preserving your resources, minimizing costs, and delivering speed without compromise.
With OmniMD-Rx, you gain direct access to certified modules for:
E-Prescribing
(all medication types)
Eligibility and
formulary checks
Electronic Prior
Authorization
Electronic Prescribing of
Controlled Substances
Advanced Capabilities You Can Rely On
What Is E-Prescribing?
E-prescribing (electronic prescribing) is the digital transmission of a prescription from a licensed prescriber directly to a pharmacy, replacing paper prescriptions, handwritten orders, and phone-in calls. The prescriber enters or confirms the prescription in the electronic health record, selects the patient’s pharmacy, and the order transmits through the Surescripts national e-prescribing network to the pharmacy within seconds of confirmation.
The Surescripts network connects more than 270,000 pharmacies across the United States. When a physician sends a prescription through OmniMD, the order routes to the patient’s pharmacy in real time. The pharmacy receives a structured electronic order with the prescriber’s DEA and NPI, the patient’s demographics, and the medication details in a standardized format that eliminates pharmacy transcription errors from handwriting.
At the point of prescribing, OmniMD checks the new medication against the patient’s active medication list for drug-drug interactions, drug-allergy conflicts, and duplicate therapies before the prescription sends. Formulary and benefit information surfaces in real time, showing the physician the patient’s out-of-pocket cost and whether a covered generic alternative is available. The physician selects the preferred option without leaving the encounter.
For controlled substances, e-prescribing extends to EPCS (Electronic Prescribing for Controlled Substances), which requires identity authentication at the point of prescribing and meets DEA requirements under 21 CFR Part 1311. In OmniMD, EPCS authentication happens within the same prescribing screen, without opening a second application or logging into a separate portal.
Research published in peer-reviewed medical informatics literature consistently shows higher prescription fill rates for electronic prescriptions than for paper. When the prescription transmits to the pharmacy before the patient leaves the office, there is nothing to lose or forget. CMS data on Medicare Part D e-prescribing adoption also correlates electronic prescribing with improved medication adherence in elderly patient populations.
OmniMD includes e-prescribing for all medication classes as part of the standard EHR platform subscription. There is no separate prescribing module to activate or pay for. Surescripts enrollment is completed during the OmniMD implementation process, typically within the first 1 to 3 business days.
How OmniMD E-Prescribing Integrates With Your Clinical Workflow
OmniMD’s e-prescribing is not a bolt-on application that connects to the EHR through an external API. It is built into the clinical workflow at the point of care. When a physician opens a patient’s chart in OmniMD, the prescribing interface draws from the same data as the rest of the record: the active medication list, allergy records, diagnosis history, and current prior authorization status all appear in context when writing a new prescription. This is the reason physicians searching for “EMR with e-prescribing built in” consistently evaluate OmniMD alongside dedicated prescribing tools.
Drug interaction alerts, formulary checks, and patient cost estimates surface automatically when the physician selects a medication. The physician dashboard does not require the provider to leave the patient chart or switch to a different application. For controlled substances, EPCS identity verification (biometric, SMS, or hardware token, depending on the authentication method enrolled during setup) completes in the same screen before the prescription routes to the pharmacy through Surescripts.
PDMP (Prescription Drug Monitoring Program) queries run within OmniMD’s prescribing screen. In states with mandatory PDMP checks before issuing controlled substances, the query result displays inside the chart without requiring a separate login to the state’s PDMP portal. OmniMD connects to state PDMP systems through its integration with DrFirst Rcopia, the same network that handles EPCS routing through Surescripts.
Prior authorization requests for medications that require insurer approval submit directly from the prescribing screen through OmniMD’s integrated ePA (electronic prior authorization) module. The result is that the entire prescribing workflow, from patient chart to pharmacy confirmation, stays in one application. Physicians using OmniMD report completing e-prescriptions during the encounter rather than queuing them for after-hours processing, reducing per-encounter documentation time.
What Is EPCS? Requirements, Compliance, and PDMP Integration
EPCS stands for Electronic Prescribing for Controlled Substances. It is the federal standard for digitally transmitting prescriptions for Schedule II, III, IV, and V medications, including opioids, stimulants, benzodiazepines, and other controlled drugs covered under the Controlled Substances Act. The DEA issued the EPCS rule under 21 CFR Part 1311 in 2010, with significant updates in 2023 and 2024 covering telemedicine prescribing.
Paper prescriptions for controlled substances can be intercepted, altered, or counterfeited. EPCS eliminates that risk. Under 21 CFR Part 1311, EPCS systems must use identity authentication protocols that make forging a controlled substance prescription cryptographically infeasible.
What EPCS Requires of Prescribers
To prescribe controlled substances electronically, a physician must complete EPCS identity proofing (verification of DEA registration and prescriber identity through an approved credential service provider), enroll in an EPCS-certified software system, and use two-factor authentication at the point of prescribing. OmniMD handles EPCS enrollment during onboarding and supports biometric authentication (fingerprint), hardware token, and SMS-based verification options.
State EPCS Mandates
More than 35 states have enacted EPCS mandates requiring all or most controlled substance prescriptions to be sent electronically rather than on paper. New York, Minnesota, Texas, Massachusetts, and Virginia are among the states with active mandates and enforcement. Many states began with opioid EPCS mandates and expanded to all Schedule II-V medications. New practices should verify their state’s current EPCS requirements at the time of licensing, as mandate scope and enforcement vary.
PDMP Integration
Prescription Drug Monitoring Programs (PDMPs) are state-operated databases that track controlled substance prescriptions across all prescribers and all pharmacies. Most states require or strongly encourage PDMP queries before issuing Schedule II opioid prescriptions, and many mandate queries before any new controlled substance prescription. In OmniMD, PDMP queries run from within the patient chart using the same DrFirst integration that handles EPCS routing. The result appears inside the encounter in seconds, without a separate login to the state’s PDMP portal.
Which Specialties Are Most Affected
EPCS affects any prescriber with a DEA registration who issues controlled substance prescriptions. The highest-volume specialties are psychiatry (daily Schedule II and IV prescriptions for stimulants, benzodiazepines, and sleep medications), pain management (Schedule II opioids), and primary care and internal medicine (opioids and stimulants for ADHD). Nurse practitioners and physician assistants with independent prescribing authority and active DEA registrations are also subject to EPCS and PDMP requirements. OmniMD’s EPCS module is certified for all licensed prescriber types, including MDs, DOs, NPs, and PAs. For practices evaluating MIPS and Promoting Interoperability requirements, OmniMD’s revenue cycle and compliance tools include EPCS activity tracking for quality reporting.
Is E-Prescribing Required by Law?
E-prescribing requirements in the United States depend on the payer program, the drug schedule, and the state where the prescriber practices. Here is what applies to most US physician practices as of 2025.
Medicare Part D (CMS mandate)
Medicare Part D has required electronic prescribing for Part D-covered drugs since January 1, 2021. Any physician prescribing medications covered under Medicare Part D is subject to this requirement, with exceptions for technological barriers, emergency prescriptions, and practices writing fewer than 100 Part D prescriptions per year. CMS can issue compliance notices and, in repeat non-compliance cases, apply payment adjustments.
MIPS Promoting Interoperability
The CMS Merit-based Incentive Payment System (MIPS) includes e-prescribing as a required measure in the Promoting Interoperability performance category. Practices that do not report e-prescribing activity receive a lower score in this category, affecting the practice’s overall MIPS payment adjustment for that reporting year. OmniMD’s ONC-certified e-prescribing module satisfies the MIPS e-prescribing measure. For MIPS documentation and revenue cycle support, see OmniMD’s AI RCM tools.
State EPCS Mandates
More than 35 states require electronic prescribing for some or all controlled substances. State mandates vary in scope: most began with Schedule II opioids and expanded over time to Schedule III-V medications. New practices should verify their specific state’s requirements when activating prescribing, as enforcement timelines and exemption criteria differ.
21st Century Cures Act
The 21st Century Cures Act requires ONC-certified EHRs to support interoperable e-prescribing. Practices using an ONC-certified EHR that is capable of e-prescribing are expected to use it. OmniMD is ONC-certified and meets all Cures Act information access and interoperability requirements, including FHIR 4.0.1 patient data exchange.
E-Prescribing for Your Specialty
Different specialties face different prescribing demands. OmniMD’s e-prescribing adapts to the clinical workflows of each area.
Psychiatry
Psychiatric prescribers manage more controlled substance classes than almost any other specialty: stimulants (Schedule II), benzodiazepines (Schedule IV), sleep medications, and buprenorphine. OmniMD’s EPCS workflow includes psychiatric-specific medication lists, smart refill templates for chronic psychiatric medications, and PDMP queries from within the chart. The authentication step for controlled substances completes at the prescribing screen without switching applications. For practices looking for a specialty-specific EHR, OmniMD’s EPCS module is built in, not added on.
Nurse Practitioners and Physician Assistants
NPs and PAs with independent prescribing authority and active DEA registrations enroll in EPCS during OmniMD onboarding and use the full prescribing capability. OmniMD supports practices where NPs and PAs carry independent patient panels in primary care, urgent care, and behavioral health settings. The prescribing workflow is identical regardless of provider type, with EPCS authentication tied to each individual prescriber’s credentials.
Telehealth and Remote Prescribing
For telehealth visits conducted through OmniMD’s platform, e-prescriptions send through the same Surescripts routing as in-person encounters. There is no separate prescribing tool for telehealth visits. For Schedule III-V controlled substances, the DEA’s 2024 EPCS telemedicine rules allow EPCS prescribing under specific conditions. Schedule II medications continue to require an in-person prescribing encounter under current DEA regulations. Remote patient monitoring integration supports follow-up prescription management for chronic condition patients.
Primary Care and Internal Medicine
High-volume prescribing practices benefit from OmniMD’s medication favorites lists, patient-specific prescription templates, and two-click refill approvals. Prescription fill history appears in the chart at the next encounter, giving the physician an immediate view of which medications the patient has been picking up.
Pain Management
Schedule II opioid prescriptions require EPCS in most states. OmniMD’s PDMP integration and EPCS workflow cover the daily prescribing volume of pain management practices. PDMP results display within the patient chart before the prescription sends, satisfying state-required query documentation.
OB-GYN
Formulary checks at the point of prescribing help OB-GYN physicians select covered medications for patients on managed care plans. Real-time patient cost display reduces the need for pharmacist callbacks. Drug interaction checks run automatically against the patient’s current medication list.
What OmniMD Physicians Report About E-Prescribing
“The most common prescribing complaint I hear from physicians transitioning to OmniMD is that they did not realize how much time paper prescribing and pharmacy callback handling were costing them per encounter. When the prescription routes to the pharmacy while the physician is still with the patient, and the pharmacy confirmation appears in the chart before the next appointment, the after-encounter administrative time drops in the first week of use. In practices with meaningful controlled substance volume, the EPCS and PDMP integration in one screen removes what was previously a 2- to 3-minute interruption at the end of each controlled substance encounter. That adds up across a full clinical day.”
Dr. Giriraj Purohit, Product Manager, OmniMD
Based on clinical implementation experience across OmniMD practices. Verified July 2026.
For physicians evaluating OmniMD, the AI medical scribe and patient portal are part of the same platform as e-prescribing, meaning prescription refill requests, medication questions through the portal, and encounter documentation all flow through the same system.
